Identification of epithelial-mesenchymal transition markers (EMT) by immunohistochemistry in pediatric osteosarcoma and association with clinical outcomes

被引:0
|
作者
V. Fonseca, Eileen [1 ]
Olaya, Natalia [2 ]
Patino, Esteban F. [3 ]
Aponte, Nelson H. [4 ]
Ballesteros, Adriana Linares [2 ]
机构
[1] Univ Nacl Colombia, Oncohematol Pediat, Bogota, Colombia
[2] Univ Nacl Colombia, Hosp Pediatr Misericordia, Fdn HOMI, Bogota, Colombia
[3] Hosp Pediatr Misericordia, Fdn HOMI, Dept Patol, Bogota, Colombia
[4] Hosp Pediatr Misericordia, Serv Oncohematol Pediat Fdn HOMI, Bogota, Colombia
来源
ANDES PEDIATRICA | 2022年 / 93卷 / 06期
关键词
Transcription Factors; Snail Family; Twist-Related Protein 1; Osteosarcoma; Epithelial-Mesenchymal Transition; TWIST; EXPRESSION;
D O I
10.32641/andespediatr.v93i6.4255
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The epithelial-mesenchymal transition (EMT) is the ability of epithelial and mesenchymal cells to exchange phenotypes transiently. Its identification in carcinomatous cells has been associated with aggressive clinical phenotypes. In sarcomas, this ability is under study. Objective: to evaluate the expression of two transcription factors involved in EMT by immunohistochemistry in pediatric os-teosarcoma and its association with clinical outcomes. Patients and Method: A retrospective cohort study in children under 18 years of age with osteosarcoma diagnosis. Immunohistochemistry was performed for Snail and Twist-1 expressions from samples collected at the time of diagnosis. Corre-lations between immunohistochemistry and the clinical outcomes and overall survival were perfor-med. Results: 53 patients were included. There were 26 positive cytoplasmic cases (49.1%) in Snail expression and were correlated with the presence of multiple metastases (p = 0.02) and distant bone metastases (p = 0.01). On the other hand, 45 cases (84.9%) were positive in Twist-1 expression in the nuclear location, showing no association with the analyzed clinical variables. Conclusions: Snail and Twist-1 were frequently expressed in pediatric cases of osteosarcoma. Cytoplasmic Snail was co-rrelated with the presence of multiple metastatic disease and distant bone metastases. The positivity of both markers suggests the activation of these proteins as regulators of EMT events in this tumor, suggesting a role in the phenomena related to the clinical presentation of the disease.
引用
收藏
页码:868 / 877
页数:10
相关论文
共 50 条
  • [41] Evidence of pazopanibinduced epithelial-mesenchymal transition (EMT) in human tumors
    Navas, Tony
    Srivastava, Apurva K.
    Ferry-Galow, Katherine
    Makhlouf, Hala
    Chuaqui, Rodrigo
    Kinders, Robert J.
    Bottaro, Donald P.
    Chen, Alice P.
    Parchment, Ralph E.
    Kummar, Shivaani
    Doroshow, James H.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [42] Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer
    Huang, Ruby Yun-Ju
    Chung, Vin Yee
    Thiery, Jean Paul
    CURRENT DRUG TARGETS, 2012, 13 (13) : 1649 - 1653
  • [43] Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding
    Lin, Lawrence Hsu
    Zamuco, Ronaldo DeLeon
    Shukla, Pratibha S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (06) : 602 - 612
  • [44] Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma
    Black, C. C.
    Byrd, R. H.
    Fohn, L. E.
    Totsas, A. D.
    Washington, M. K.
    Cates, J. M.
    LABORATORY INVESTIGATION, 2008, 88 : 113A - 113A
  • [45] Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma
    Black, C. C.
    Byrd, R. H.
    Fohn, L. E.
    Tatsas, A. D.
    Washington, M. K.
    Cates, J. M.
    MODERN PATHOLOGY, 2008, 21 : 113A - 113A
  • [46] MicroRNAs as markers of epithelial-mesenchymal transition in colorectal cancerogenesis
    Rankovic, B.
    Bostjaneie, E.
    Zlajpah, M.
    Zidar, N.
    VIRCHOWS ARCHIV, 2018, 473 : S13 - S13
  • [47] Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal Adenocarcinoma
    Cates, Justin M. M.
    Byrd, Robert H.
    Fohn, Laurel E.
    Tatsas, Armanda D.
    Washington, Mary K.
    Black, Candice C.
    PANCREAS, 2009, 38 (01) : E1 - E6
  • [48] Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
    Du, Bowen
    Shim, Joong Sup
    MOLECULES, 2016, 21 (07):
  • [49] A new dimension in drug discovery: reversing epithelial-mesenchymal transition (EMT)
    Huang, Ruby Yun-Ju
    Huang, Thomas Yo-Yan
    CELL DEATH & DISEASE, 2016, 7 : e2417 - e2417
  • [50] Epithelial-mesenchymal transition (EMT) of renal tubular cells in canine glomerulonephritis
    Aresu, Luca
    Rastaldi, Maria Pia
    Scanziani, Eugenio
    Baily, James
    Radaelli, Enrico
    Pregel, Paola
    Valenza, Federico
    VIRCHOWS ARCHIV, 2007, 451 (05) : 937 - 942